Details for New Drug Application (NDA): 050551
✉ Email this page to a colleague
NDA 050551 describes CEFOBID, which is a drug marketed by Pfizer and is included in three NDAs. Additional details are available on the CEFOBID profile page.
The generic ingredient in CEFOBID is cefoperazone sodium. There are four drug master file entries for this compound. Additional details are available on the cefoperazone sodium profile page.
The generic ingredient in CEFOBID is cefoperazone sodium. There are four drug master file entries for this compound. Additional details are available on the cefoperazone sodium profile page.
Summary for 050551
| Tradename: | CEFOBID |
| Applicant: | Pfizer |
| Ingredient: | cefoperazone sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050551
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | Nov 18, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
| Approval Date: | Nov 18, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 10GM BASE/VIAL | ||||
| Approval Date: | Mar 5, 1990 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
